335 related articles for article (PubMed ID: 17507552)
1. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
Petzinger GM; Walsh JP; Akopian G; Hogg E; Abernathy A; Arevalo P; Turnquist P; Vucković M; Fisher BE; Togasaki DM; Jakowec MW
J Neurosci; 2007 May; 27(20):5291-300. PubMed ID: 17507552
[TBL] [Abstract][Full Text] [Related]
2. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia.
Fisher BE; Petzinger GM; Nixon K; Hogg E; Bremmer S; Meshul CK; Jakowec MW
J Neurosci Res; 2004 Aug; 77(3):378-90. PubMed ID: 15248294
[TBL] [Abstract][Full Text] [Related]
3. Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
VanLeeuwen JE; Petzinger GM; Walsh JP; Akopian GK; Vuckovic M; Jakowec MW
J Neurosci Res; 2010 Feb; 88(3):650-68. PubMed ID: 19746427
[TBL] [Abstract][Full Text] [Related]
4. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
5. Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
Vucković MG; Wood RI; Holschneider DP; Abernathy A; Togasaki DM; Smith A; Petzinger GM; Jakowec MW
Neurobiol Dis; 2008 Nov; 32(2):319-27. PubMed ID: 18718537
[TBL] [Abstract][Full Text] [Related]
6. Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.
Gorton LM; Vuckovic MG; Vertelkina N; Petzinger GM; Jakowec MW; Wood RI
Behav Brain Res; 2010 Dec; 213(2):253-62. PubMed ID: 20472000
[TBL] [Abstract][Full Text] [Related]
7. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
[TBL] [Abstract][Full Text] [Related]
8. Treadmill exercise modifies dopamine receptor expression in the prefrontal cortex of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of Parkinson's disease.
Kintz N; Petzinger GM; Jakowec MW
Neuroreport; 2017 Oct; 28(15):987-995. PubMed ID: 28877102
[TBL] [Abstract][Full Text] [Related]
9. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
11. Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse.
Smith BA; Goldberg NR; Meshul CK
Brain Res; 2011 Apr; 1386():70-80. PubMed ID: 21315689
[TBL] [Abstract][Full Text] [Related]
12. Exercise intervention increases spontaneous locomotion but fails to attenuate dopaminergic system loss in a progressive MPTP model in aged mice.
Hood RL; Liguore WA; Moore C; Pflibsen L; Meshul CK
Brain Res; 2016 Sep; 1646():535-542. PubMed ID: 27350080
[TBL] [Abstract][Full Text] [Related]
13. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
[TBL] [Abstract][Full Text] [Related]
14. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of phenylethanoid glycosides from Cistanches salsa against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice.
Geng X; Song L; Pu X; Tu P
Biol Pharm Bull; 2004 Jun; 27(6):797-801. PubMed ID: 15187420
[TBL] [Abstract][Full Text] [Related]
16. Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Park J; Lim CS; Seo H; Park CA; Zhuo M; Kaang BK; Lee K
Mol Pain; 2015 May; 11():28. PubMed ID: 25981600
[TBL] [Abstract][Full Text] [Related]
17. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD.
Jang Y; Kwon I; Song W; Cosio-Lima LM; Taylor S; Lee Y
Life Sci; 2018 Sep; 209():455-465. PubMed ID: 30144449
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease.
Depboylu C; Schorlemmer K; Klietz M; Oertel WH; Weihe E; Höglinger GU; Schäfer MK
J Neuroimmunol; 2011 Jul; 236(1-2):39-46. PubMed ID: 21640391
[TBL] [Abstract][Full Text] [Related]
19. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
Leng A; Mura A; Hengerer B; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
[TBL] [Abstract][Full Text] [Related]
20. Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease.
Kim SN; Doo AR; Park JY; Bae H; Chae Y; Shim I; Lee H; Moon W; Lee H; Park HJ
PLoS One; 2011; 6(11):e27566. PubMed ID: 22132113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
